Chorioretinal Lesions in a Case of Melanoma-Associated Retinopathy Treated With Pembrolizumab-Reference-Cited by-同舟云学术

Chorioretinal Lesions in a Case of Melanoma-Associated Retinopathy Treated With Pembrolizumab

Published:2016-10-01 Issue:10 Volume:134 Page:1184
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Roberts Philipp¹,Fishman Gerald A.²,Joshi Komal³,Jampol Lee M.³

Affiliation:

1. Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois2Department of Ophthalmology, Medical University of Vienna, Vienna, Austria

2. The Chicago Lighthouse for People Who Are Blind or Visually Impaired, Chicago, Illinois

3. Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis;BMC Ophthalmology;2024-07-29

2. LPCAT1 promotes melanoma cell proliferation via Akt signaling;Oncology Reports;2024-03-26

3. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04

4. Tuberculosis reactivation demonstrated by choroiditis and inflammatory choroidal neovascular membrane in a patient treated with immune checkpoint inhibitors for malignant mucosal melanoma;Journal of Ophthalmic Inflammation and Infection;2023-12-18

5. Tuberculosis Reactivation Demonstrated By Choroiditis And Inflammatory Choroidal Neovascular Membrane In A Patient Treated With Immune Checkpoint Inhibitors For Malignant Mucosal Melanoma;2023-09-14